in this issue
World News and Views :: Projects
Carbogen Amcis to Open High Potency API Unit in India
12:29 PM MDT | April 18, 2008 | Deepti Ramesh
Research and active pharma ingredient (API) manufacturer Carbogen Amcis AG (Bubendorf, Switzerland) says that its Indian subsidiary Carbogen Amcis India Ltd. (Ahmedabad, India) will open a facility for high potency APIs at Bavla, India by the first quarter of 2009. The Bavla facility, which is at the site of parent firm Dishman Pharmaceuticals & Chemicals Ltd., will cater to both cytotoxic and non-cytotoxic highly active substances in dedicated areas. Construction is under way, says Carbogen Amcis, which is designing the facility and plans to operate it...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee